Literature DB >> 22364636

Plasma testosterone is associated with Framingham risk score.

Brandon Chock1, Tzu-Chun Lin, Chin-Shang Li, Arthur Swislocki.   

Abstract

INTRODUCTION: The Framingham risk score predicts a patient's 10-year risk of developing cardiovascular disease. Many risk factors included in its calculation influence or are influenced by circulating testosterone. To investigate the possible association between testosterone and cardiovascular risk, as defined by the Framingham score, a Veterans Affairs (VA) database was analyzed.
METHODS: A retrospective chart review was performed. Inclusion criteria were male sex and age ≥ 20 years. Exclusion criteria included pre-existing cardiovascular disease, stroke, and diabetes. Data were collected on veterans who had total plasma testosterone checked in the year 2008.
RESULTS: The study included 1,479 patients (mean age 61 years). Framingham score was negatively associated with both total testosterone (p < 0.0001) and free testosterone (p = 0.0003). There was a positive association between total testosterone and high-density lipoprotein and negative associations between total testosterone and body mass index (BMI), total cholesterol, triglycerides, and blood pressure medication use. Free testosterone was positively associated with total cholesterol, low-density lipoprotein, and current smoking status and negatively associated with age, BMI, and blood pressure medication use. The BMI was not associated with Framingham score.
CONCLUSIONS: Lower plasma testosterone may suggest the presence of cardiovascular risk factors and potentially increased risk for heart disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22364636     DOI: 10.3109/13685538.2011.654369

Source DB:  PubMed          Journal:  Aging Male        ISSN: 1368-5538            Impact factor:   5.892


  7 in total

1.  Testosterone is negatively associated with the severity of coronary atherosclerosis in men.

Authors:  Li Li; Chang-Yan Guo; En-Zhi Jia; Tie-Bing Zhu; Lian-Sheng Wang; Ke-Jiang Cao; Wen-Zhu Ma; Zhi-Jian Yang
Journal:  Asian J Androl       Date:  2012-10-08       Impact factor: 3.285

Review 2.  Androgens and stroke: good, bad or indifferent?

Authors:  Nidia Quillinan; Guiying Deng; Himmat Grewal; Paco S Herson
Journal:  Exp Neurol       Date:  2014-02-08       Impact factor: 5.330

3.  Integrated molecular landscape of Parkinson's disease.

Authors:  J E Visser; G Poelmans; C J H M Klemann; G J M Martens; M Sharma; M B Martens; O Isacson; T Gasser
Journal:  NPJ Parkinsons Dis       Date:  2017-04-10

Review 4.  Sex-Associated Differences in Neurovascular Dysfunction During Ischemic Stroke.

Authors:  Tianchi Tang; Libin Hu; Yang Liu; Xiongjie Fu; Jianru Li; Feng Yan; Shenglong Cao; Gao Chen
Journal:  Front Mol Neurosci       Date:  2022-04-01       Impact factor: 6.261

5.  Testosterone Level Reduction Increases the 10-Year Risk of Cardiovascular Diseases: A Retrospective Cohort Study in a Taiwanese Young Male Population.

Authors:  Han-Hsuan Yang; Shih-Kai Tu; Hsin-Hung Chen; Chia-Lien Hung; Chia-Wen Kuo; Yu-Tse Tsan; Wei-Min Chu; Meng-Chih Lee; Chun-Cheng Liao
Journal:  Front Cardiovasc Med       Date:  2022-04-14

6.  Analysis of the association and predictive value of hyperhomocysteinaemia for obstructive coronary artery disease.

Authors:  Hao-Yu Wu; Tian-Jiao Gao; Yi-Wei Cao; Jia-Yu Diao; Peng-Hua You; Xiao-Wei Yao
Journal:  J Int Med Res       Date:  2021-07       Impact factor: 1.671

7.  Impaired fecundity as a marker of health and survival: a Danish twin cohort study.

Authors:  L J Ahrenfeldt; S Möller; M J Wensink; M L Eisenberg; K Christensen; T K Jensen; R Lindahl-Jacobsen
Journal:  Hum Reprod       Date:  2021-07-19       Impact factor: 6.918

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.